Charles S. Carter

4.2k total citations · 1 hit paper
30 papers, 2.9k citations indexed

About

Charles S. Carter is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Charles S. Carter has authored 30 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 14 papers in Hematology and 9 papers in Oncology. Recurrent topics in Charles S. Carter's work include Immune Cell Function and Interaction (16 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Immunotherapy and Immune Responses (8 papers). Charles S. Carter is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Immunotherapy and Immune Responses (8 papers). Charles S. Carter collaborates with scholars based in United States, Malaysia and South Africa. Charles S. Carter's co-authors include Susan F. Leitman, Elizabeth J. Read, Steven A. Rosenberg, Joost J. Oppenheim, Stephen I. Katz, Daniel N. Sauder, Harvey G. Klein, Linda Muul, R. Michael Blaese and Craig A. Mullen and has published in prestigious journals such as Science, New England Journal of Medicine and Nature Medicine.

In The Last Decade

Charles S. Carter

30 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T Lymphocyte-Directed Gene Therapy for ADA ⁻ SCID: Initial Trial Results After 4 Years

1995 983 citations R. Michael Blaese, Charles S. Carter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles S. Carter United States	20	1.3k	1.1k	1.1k	936	513	30	2.9k
Brigitte Sénéchal United States	18	1.6k 1.2×	813 0.8×	631 0.6×	2.3k 2.4×	307 0.6×	43	4.0k
Maria-Grazia Roncarolo Italy	29	4.9k 3.7×	812 0.8×	957 0.9×	1.1k 1.2×	552 1.1×	43	6.4k
A E Namen United States	21	3.1k 2.4×	803 0.7×	354 0.3×	974 1.0×	520 1.0×	33	4.2k
R. L. H. Bolhuis Netherlands	37	3.2k 2.4×	795 0.7×	484 0.5×	2.0k 2.1×	315 0.6×	105	4.6k
Petter Höglund Sweden	38	4.6k 3.5×	570 0.5×	737 0.7×	1.1k 1.1×	531 1.0×	119	5.6k
Satoru Kumaki Japan	25	3.5k 2.6×	606 0.6×	300 0.3×	1.1k 1.1×	301 0.6×	74	4.3k
Laura Bover United States	26	2.3k 1.8×	936 0.9×	329 0.3×	926 1.0×	95 0.2×	58	3.7k
Matthias Wölfl Germany	20	2.2k 1.6×	634 0.6×	381 0.4×	1.3k 1.4×	252 0.5×	57	3.0k
Michele Cottler‐Fox United States	36	1.0k 0.8×	1.5k 1.4×	662 0.6×	1.4k 1.5×	2.5k 4.8×	140	4.2k
A. Lindemann Germany	32	1.8k 1.3×	749 0.7×	467 0.4×	1.1k 1.2×	892 1.7×	87	3.3k

Countries citing papers authored by Charles S. Carter

Since Specialization

Citations

This map shows the geographic impact of Charles S. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Carter more than expected).

Fields of papers citing papers by Charles S. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Carter. The network helps show where Charles S. Carter may publish in the future.

Co-authorship network of co-authors of Charles S. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Carter. A scholar is included among the top collaborators of Charles S. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Carter. Charles S. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Montero, Aldemar, Bipin N. Savani, Aarthi Shenoy, et al.. (2006). T Cell Depleted Peripheral Blood Stem Cell Allotransplantation with T Cell Add Back for Patients with Hematological Malignancies: Effect of Chronic GVHD on Outcome. Biology of Blood and Marrow Transplantation. 12(12). 1318–1325. 38 indexed citations

2.

Kurlander, Roger, Abdul Tawab, Yong Fan, Charles S. Carter, & Elizabeth J. Read. (2006). A functional comparison of mature human dendritic cells prepared in fluorinated ethylene‐propylene bags or polystyrene flasks. Transfusion. 46(9). 1494–1504. 19 indexed citations

3.

Khuu, Hanh, et al.. (2006). Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR‐compliant method. Transfusion. 46(12). 2071–2082. 35 indexed citations

4.

Morgan, Richard A., Robert Walker, Charles S. Carter, et al.. (2005). Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals. Human Gene Therapy. 0(0). 620347321–620347321. 2 indexed citations

5.

Morgan, Richard A., Robert Walker, Charles S. Carter, et al.. (2005). Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals. Human Gene Therapy. 16(9). 1065–1074. 55 indexed citations

6.

Zhang, Hua, Kevin Chua, Martin Guimond, et al.. (2005). Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nature Medicine. 11(11). 1238–1243. 310 indexed citations

7.

Bolan, Charles D., Charles S. Carter, Robert Wesley, et al.. (2003). Prospective evaluation of cell kinetics, yields and donor experiences during a single large‐volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cells. British Journal of Haematology. 120(5). 801–807. 21 indexed citations

8.

Solomon, Scott R., Charles S. Carter, John Schindler, et al.. (2002). Optimized clinical-scale culture conditions for ex vivoselective depletion of host-reactive donor lymphocytes: astrategy for GVHD prophylaxis in allogeneic peripheral bloodstem cell transplantation. Cytotherapy. 4(5). 1 indexed citations

9.

Dagher, Ramzi, Lauren Long, Elizabeth J. Read, et al.. (2002). Pilot trial of tumor‐specific peptide vaccination and continuous infusion interleukin‐2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter‐institute NIH study†. Medical and Pediatric Oncology. 38(3). 158–164. 118 indexed citations

10.

Nakamura, Ryotaro, Erkut Bahceci, Elizabeth J. Read, et al.. (2001). Transplant dose of CD34⁺ and CD3⁺ cells predicts outcome in patients with haematological malignancies undergoing T cell‐depleted peripheral blood stem cell transplants with delayed donor lymphocyte add‐back. British Journal of Haematology. 115(1). 95–104. 53 indexed citations

11.

Horwitz, Mitchell E., A. John Barrett, Margaret R. Brown, et al.. (2001). Treatment of Chronic Granulomatous Disease with Nonmyeloablative Conditioning and a T-Cell–Depleted Hematopoietic Allograft. New England Journal of Medicine. 344(12). 881–888. 198 indexed citations

12.

Liu, Johnson M., Sonnie Kim, Elizabeth J. Read, et al.. (1999). Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC). Human Gene Therapy. 10(14). 2337–2346. 97 indexed citations

13.

Walker, Robert, Charles S. Carter, Linda Muul, et al.. (1998). Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nature Medicine. 4(7). 852–856. 99 indexed citations

14.

Mackall, Crystal L., Catherine V. Bare, Margaret R. Brown, et al.. (1996). IMPAIRED IMMUNE RECONSTITUTION POST SEQUENTIAL HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL BLOOD PROGENITOR CELL (PBPC) INFUSION. † 962. Pediatric Research. 39. 163–163. 1 indexed citations

15.

Alexander, Richard B., Ellen Fitzgerald, Arnold Mixon, et al.. (1995). Helper T Cells Infiltrating Human Renal Cell Carcinomas Have the Phenotype of Activated Memory-Like T Lymphocytes. Journal of Immunotherapy. 17(1). 39–46. 18 indexed citations

16.

Pockaj, Barbara A., Richard M. Sherry, John P. Wei, et al.. (1994). Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response. Cancer. 73(6). 1731–1737. 166 indexed citations

17.

Walker, Robert, Charles S. Carter, Lauren A. Chang, et al.. (1993). A Study of the Safety and Survival of the Adoptive Transfer of Genetically Marked Syngeneic Lymphocytes in HIV-infected Identical Twins. Human Gene Therapy. 4(5). 659–680. 21 indexed citations

18.

Hoffman, Thomas, Young Lim Lee, Elaine F. Lizzio, et al.. (1991). Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1β, or TNF-α production by human monocytes in vitro. Clinical Immunology and Immunopathology. 58(3). 399–408. 16 indexed citations

19.

Aebersold, Paul, et al.. (1988). A simplified automated procedure for generation of human lymphokine-activated killer cells for use in clinical trials. Journal of Immunological Methods. 112(1). 1–7. 10 indexed citations

20.

Muul, Linda, Kathryn Nason-Burchenal, Charles S. Carter, et al.. (1987). Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy. Journal of Immunological Methods. 101(2). 171–181. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact